Advertisement

Ads Placeholder
Loading...

Astellas Pharma Inc.

ALPMY•PNK
Healthcare
Drug Manufacturers - General
$16.54
$-0.25(-1.46%)
U.S. Market is Open • 15:37

Astellas Pharma Inc. (ALPMY) Stock Overview

Explore Astellas Pharma Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap29.5B
P/E Ratio14.45
EPS (TTM)$0.43
ROE0.20%
Fundamental Analysis

AI Price Forecasts

1 Month$15.15
3 Months$20.93
1 Year Target$14.50

ALPMY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Astellas Pharma Inc. (ALPMY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.83, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $14.50.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.45 and a market capitalization of 29.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.79%
5-Day Change
2.55%
1-Month Change
8.56%
3-Month Change
23.72%
6-Month Change
49.55%
Year-to-Date (YTD) Change
23.72%
1-Year Change
78.74%
3-Year Change
17.05%
5-Year Change
5.71%
All-Time (Max) Change
114.58%

Contact Information

https://www.astellas.com
81 3 3244 3000
2-5-1, Nihonbashi-Honcho, Tokyo, NaN, 103-8411

Company Facts

147,540 Employees
IPO DateDec 29, 2009
CountryJP
Actively Trading

Frequently Asked Questions